Compounds > 3,3',4,5'-tetrahydroxystilbene
Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Diabetic Cardiomyopathies

3,3',4,5'-tetrahydroxystilbene has been researched along with Diabetic Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, M; Li, H; Li, P; Ren, Y; Rong, X; Shi, Y; Wang, X; Wu, R; Wu, T; Xia, T; Yan, Y; Zhan, Y; Zhang, S1

Other Studies

1 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Diabetic Cardiomyopathies

ArticleYear
Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy.
    Chemico-biological interactions, 2019, Sep-01, Volume: 310

    Topics: Animals; Cell Line; Diabetic Cardiomyopathies; Heme Oxygenase-1; Humans; Inflammation; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Signal Transduction; Stilbenes

2019